Research Shows How To Avoid Misleading With Statistics

Published Sep 17, 2012
Ann Arbor, MI, USA – Research conducted by the University of Michigan School of Public Health shows that when researchers compare two or more treatments, the choice of how to express results may affect their conclusion about which is best. Using a mathematical model and a sophisticated software program, Edward Norton, PhD, and his team demonstrated that the choice between risk ratio, odds ratio and risk difference could result in different outcomes through what is called rank reversal. Previous research has suggested that rankings through indirect comparisons can be assumed to be consistent across the various methods. Norton said, “The outcome of the team’s research impacts best practices for making indirect comparisons.” He continued on to say, “With the government funding more research that uses these different methods, researchers need to be aware that the method they choose could influence the conclusion." The paper, “Rank Reversal in Indirect Comparisons,” is published in Value in Health.

Value in Health (ISSN 1098-3015) publishes papers, concepts, and ideas that advance the field of pharmacoeconomics and outcomes research as well as policy papers to help health care leaders make evidence-based decisions. The journal is published bi-monthly and has over 8,000 subscribers (clinicians, decision makers, and researchers worldwide).

International Society for Pharmacoeconomics and Outcomes Research (ISPOR) is a nonprofit, international, educational and scientific organization that strives to increase the efficiency, effectiveness, and fairness of health care resource use to improve health. For more information: www.ispor.org

Related Stories

Promoting Fairness in Funding Decisions

Jun 24, 2026

Value in Health announced the publication of a special themed section of research papers that offer new tools to help health policy makers weigh fairness alongside cost-effectiveness when deciding which treatments and programs to fund.

Listening to Patients in the Real World

Jun 23, 2026

Value in Health, the official journal of ISPOR announced today the publication of an ISPOR Good Practices Report outlining 9 areas to strengthen the robustness, transparency, and feasibility of real-world patient-reported outcomes studies.

ISPOR Task Force Addresses Critical Gap in Surrogate Endpoint Guidance

May 28, 2026

Value in Health, announced the publication of an ISPOR Good Practices Report providing guidance on the use of surrogate endpoint evaluation methods in health technology assessment (HTA) decision making. The report, “Methods for Evaluation of Surrogate Endpoints for HTA Decision Making: A Good Practices Report of an ISPOR Task Force,” was published in the May 2026 issue of Value in Health.
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×